“Understanding how the repertoire of immune cells fits with the diverse landscape of brain cancer types can help us find new ...
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
Driving Restrictions Beyond 1 Month After CAR-T Therapy Not Needed for All Patients, Researchers Say
Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.
Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...
India Today on MSN5d
Indian biotech firm pioneers CAR-T cell therapy for cancer treatmentBi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat ...
Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...
Treatment of B-cell Acute Lymphoblastic Leukaemia has been greatly improved by CAR-T therapies, but relapse is still very common. An international team has now found in animal models a new approach ...
A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to ...
Multiple presentations demonstrate that T-knife's proprietary next-generation technologies address important challenges with current cell therapy constructs, including boosting T cell fitness and pers ...
Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback